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Gynecologic cancer in Brazil and the law of sixty days
Administrative Order MS/GM 876/13, with the objective of determining that the maximum period of 60 days to start treatment should begin from the signature of the pathological report.
In order to evaluate whether the "Law of 60 days" changed the patients' access to treatment, we used the NHRC database and compared patients from the years 2009/2012 (group A, n=43,614 patients) and 2013/2016 (group B, n=19,212), an interval covering the 4 years before and after the law came into force ( Table 1) .
In this short follow-up, a minimal change occurred. Considering only the valid data (excluding 28.2% of missing information), in group A, 59.6% of the population initiated treatment according to the law (within 60 days) compared to 60.2% in group B (p>0.05). However, at least 26% of the patients in group A, and 24% in group B, started treatment more than 90 days after diagnosis ( Table 1) .
But what barriers could be associated with this unfavorable scenario? Why are patients still waiting in long lines for treatment? There are many factors associated with it.
Here we highlight what we believe to be the most important obstacles:
• Delays in scheduling medical appointments: as some reports show, the queues are long for patients who need assistance. In a report, the average waiting time for primary care in public health in Brazil was 15 days, reaching 50.2 days for care at a secondary level (general hospitals) [5] . According to the INCA, there are 288 tertiary cancer centers in the country, most of which are concentrated in the south and southeast regions, and a lack of tertiary cancer centers in the less populated and developed areas [6] .
• Shortage of chemotherapeutic agents: The Regional Medical Council of Rio de Janeiro (CREMERJ) and the Public Defender of the Union (DPU) presented on March 2017, a survey conducted between October and November 2016 that pointed to failures of the State in cancer care. There was a shortage of chemotherapeutic agents in 42% of the 19 public hospitals treating oncologic patients. Moreover, they found that this is a recurring problem [7] .
• Late pathological and Immunohistochemistry reports: in the same survey conducted in Rio de Janeiro in 2016, the average time was 4 weeks and 8 weeks, respectively, to obtain results from the pathology report and immunohistochemistry [6] .
• Shortage of radiotherapy machines and human resources: there is a lack of machines in the public system as well as human resources. In a recent article on the current needs for radiotherapy in the Brazilian public health system, a deficit was shown in 2015 of 255 radiotherapy machines, 387 radiation oncologists, and 546 radiation physicists [8] . • Lack of equipped hospitals: a survey conducted by the Brazilian Federal Council of Medicine (CFM) demonstrated that Brazil had 311,917 inpatient beds in 2015, which is considered to be insufficient by CFM and 7% less than 2011. Concerning intensive care unit (ICU) beds, 86% of the cities in Brazil did not have public ICU beds. The World Health Organization does not establish a rate of hospital beds, but Brazil's number is even lower than the average rate worldwide (2.3 and 2.7/1,000 patients, respectively) [9] .
Since many gynecological cancers are related to human papillomavirus (HPV) infection (cervical, vulvar, and vaginal cancers), it would be important to take a step forward to improve preventive strategies, such as cervical screening and vaccination. Indeed, the Brazilian government included in 2017 the HPV vaccine for boys between the ages of 11 and 15 years old and extended the vaccination temporarily for both sexes until the age of 26 years old, for better coverage of the population. Some other important steps should be to improve women's health education, the amount of equipment, radiation oncologists, and perhaps centralization of care.
In summary, we are far from achieving an adequate form of care in gynecologic cancer in Brazil. It may be a potentially short time to evaluate a big difference, specially because there have been some misinterpretations of the law. Despite the best results after the "Law of 60 Days," the difference is minimal before and after the law came into effect and we can still observe long waiting times for the first treatment with a considerable proportion of patients waiting more than 90 days. It seems that a federal law that aims to ensure faster treatment will not work if there is not a deep restructuring of the system. If our government and politicians do not do their homework, giving priority to funding and investments in cancer care, we will not see an impact in the near future and our women may face even longer queues as the incidence of cancer tends to increase.
